Temporal changes and regional differences in treatment uptake of hepatitis <scp>C</scp> therapy in <scp>EuroSIDA</scp>

Daniel Grint(London School of Hygiene & Tropical Medicine), Vincent Soriano(Fundación Instituto Valenciano de Oncología), Marek Beniowski, Ole Kirk(University of Copenhagen), Carolynne Schwarze‐Zander(University Hospital Bonn), Christian Pradier(Université Côte d'Azur), Manuel Battegay(University Hospital of Basel), Amanda Mocroft(University of Copenhagen), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Djordje Jevtović, Lars Peters(University of Copenhagen), JK Rockstroh(University of Bonn)
HIV Medicine
July 19, 2013
10.1111/hiv.12068
Cited by 47

Related Papers

Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987